Ocugen Inc (OCGN)
0.9074
+0.01
(+0.72%)
USD |
NASDAQ |
Nov 22, 16:00
0.90
-0.01
(-0.82%)
After-Hours: 20:00
Ocugen Revenue (TTM): 4.70M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.70M |
| June 30, 2024 | 7.263M |
| March 31, 2024 | 6.607M |
| Date | Value |
|---|---|
| December 31, 2023 | 6.036M |
| September 30, 2023 | 7.115M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.70M
Minimum
Sep 2024
7.263M
Maximum
Jun 2024
6.344M
Average
6.607M
Median
Mar 2024
Revenue (TTM) Benchmarks
| Cytokinetics Inc | 3.219M |
| Scholar Rock Holding Corp | -- |
| Mirum Pharmaceuticals Inc | 307.03M |
| SpringWorks Therapeutics Inc | 135.49M |
| NeuroBo Pharmaceuticals Inc | -- |